Single-dose pilot study of oral rivaroxaban in pediatric subjects with venous thromboembolism

Mise à jour : Il y a 5 ans
Référence : EUCTR2009-017313-30

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to investigate pharmacokinetics and pharmacodynamics of single oral doses of rivaroxaban in paediatric subjects in order to obtain weight adjusted doses with equivalent exposure compared to 10 mg and 20 mg doses in adults.


Critère d'inclusion

  • Venous Thromboembolism